Continuous lenalidomide treatment for newly diagnosed multiple myeloma
Continuous
<br>Lenalidomide Treatment for Newly Diagnosed Multiple Myeloma
<br>N Engl J Med 2012; 366:1759-1769May 10, 2012, DOI: 10.1056/NEJMoa1112704
<br>
<br>Antonio Palumbo, M.D., Roman Hajek, M.D., Ph.D., Michel Delforge, M.D., Ph.D.,
<br>
<br>Martin Kropff, M.D., Maria Teresa Petrucci, M.D., John Catalano, M.B., B.S.,
<br>Heinz Gisslinger, M.D., Wies?aw Wiktor-Je;drzejczak, M.D., Ph.D.,
<br>Mamia Zodelava, M.D., Ph.D., Katja Weisel, M.D., Nicola Cascavilla,
<br> M.D., Genadi Iosava, M.D., Michele Cavo, M.D., Janusz Kloczko, M.D., Ph.D.,
<br>Joan Bladé, M.D., Meral Beksac, M.D., Ivan Spicka, M.D., Ph.D., Torben Plesner, M.D.,
<br>Joergen Radke, M.D., Christian Langer, M.D., Dina Ben Yehuda, M.D., Alessandro Corso, M.D.,
<br>Lindsay Herbein, B.S., Zhinuan Yu, Ph.D., Jay Mei, M.D., Ph.D., Christian Jacques, M.D., and
<br>Meletios A. Dimopoulos, M.D. for the MM-015 Investigators
